India Trial Waivers: New Drugs, CGTs Cleared In Specific Countries To Qualify

 
• By Anju Ghangurde

Drugs in specific categories that have passed regulatory muster in certain advanced markets, including the US and Japan, will be eligible for trial waivers in India, raising sponsors’ hopes for an accelerated and more streamlined approval process in the country.

More Clarity In India Clinical Trial Waiver Rules • Source: Shutterstock

More from India

More from Asia